Enhancement of basophil chemotaxis in vitro by virus-induced interferon.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 370598)

Published in J Clin Invest on February 01, 1981

Authors

M A Lett-Brown, M Aelvoet, J J Hooks, J A Georgiades, D O Thueson, J A Grant

Articles cited by this

Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol (1976) 7.06

Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58

The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22

The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J Immunol (1974) 3.88

Viruses as precipitants of asthmatic attacks in children. JAMA (1974) 3.30

Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01

The role of allergy in viral respiratory tract infections. Am J Dis Child (1962) 2.52

Histamine augments leukocyte adenosine 3',5'-monophosphate and blocks antigenic histamine release. Science (1971) 2.47

Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol (1975) 2.09

Cytochalasin B. IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes. J Immunol (1972) 2.04

The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J Immunol (1975) 2.01

Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr (1978) 2.01

Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99

Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy (1973) 1.86

Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73

Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol (1979) 1.72

The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy (1970) 1.70

Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67

Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61

Interferons and the immune system. Nature (1980) 1.42

Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators. J Immunol (1977) 1.40

Increased response of asthmatic subjects to methacholine after influenza vaccine. J Allergy (1966) 1.35

Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol (1979) 1.15

Common pathways of interferon and hormonal action. Nature (1980) 1.10

Interferon enhances the expression of Fc gamma receptors. J Immunol (1980) 1.08

Interferon-induced enhancement of IgE-mediated histamine release from human basophils requires RNA synthesis. J Immunol (1979) 1.07

Relationships of the structure and function of the interferon receptor to hormone receptors and establishment of the antiviral state. Cancer Res (1978) 1.04

Appearance of basophils in the sputum of patients with bronchial asthma. Clin Allergy (1975) 0.99

Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J Immunol (1976) 0.97

Effect of interferon on concentrations of cyclic nucleotides in cultured cells. Proc Natl Acad Sci U S A (1979) 0.94

Histamine-induced inhibition of normal human basophil chemotaxis to C5a. J Immunol (1977) 0.94

The probable role of interferon in allergy. Ann Allergy (1975) 0.92

Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines. Clin Exp Immunol (1980) 0.91

Wheezing associated with respiratory tract infections in children. The role of specific infectious agents in allergic respiratory manifestations. Clin Pediatr (Phila) (1966) 0.90

Basophil leukocytes and mast cells in human nasal secretions and scrapings studied by light microscopy. Lab Invest (1979) 0.88

Inhibition of interferon action by cytochalasin B, colchicine, and vinblastine. Proc Soc Exp Biol Med (1976) 0.86

An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state. Biochem Biophys Res Commun (1977) 0.86

A method for staining multiple chemotaxis filters. J Immunol Methods (1975) 0.84

Existence of basophil chemotaxis in subjects with hay fever. J Allergy Clin Immunol (1980) 0.79

Articles by these authors

Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58

Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol (1983) 4.25

The foamy viruses. Bacteriol Rev (1975) 2.53

A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50

Hereditary angioedema: its diagnostic and management perspectives. Am J Med (1990) 2.50

Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem (1993) 2.46

Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg (2001) 2.38

Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24

Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature (1979) 2.17

Quantitative evaluation of a screening program. Am J Public Health (1974) 2.00

Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99

Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect Immun (1979) 1.89

Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85

Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother (1977) 1.79

Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med (1996) 1.75

Contribution of general practitioner hospitals in Scotland. Br Med J (Clin Res Ed) (1984) 1.74

Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73

Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73

Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol (1979) 1.72

A closer look at water-related geologic activity on Mars. Science (2007) 1.71

Infection of human cell cultures with bovine visna virus. J Gen Virol (1978) 1.70

Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest (1992) 1.66

Volatile and organic compositions of sedimentary rocks in Yellowknife Bay, Gale crater, Mars. Science (2013) 1.65

Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun (1996) 1.59

Community hospitals--time to come off the fence. J R Coll Gen Pract (1989) 1.57

Large-scale production and partial purification of mouse immune interferon. Infect Immun (1979) 1.57

Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52

Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52

Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol (1989) 1.52

Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood (2000) 1.51

Classification of interferons with antibody to immune interferon. Cell Immunol (1980) 1.49

RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49

Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48

A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J Neurosci Res (1993) 1.45

Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma. J Infect Dis (1991) 1.43

Monstrous, crablike hypertrophy of the cerebellar vermis and its relationship with Lhermitte-Duclos disease. Case report. J Neurosurg (1996) 1.39

Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b. Virology (1987) 1.34

Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils. J Immunol (1989) 1.30

Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med (1992) 1.27

Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26

The intrinsic helix-forming tendency of L-alanine. Proc Natl Acad Sci U S A (1992) 1.26

Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol (1994) 1.26

Isolation of a new simian foamy virus from a spider monkey brain culture. Infect Immun (1973) 1.26

HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis (1986) 1.25

Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J Immunol (1990) 1.23

Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23

Characteization and distribution of two new foamy viruses isolated from chimpanzees. Arch Gesamte Virusforsch (1972) 1.21

Complement-mediated release of histamine from human leukocytes. J Immunol (1975) 1.20

Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes. J Immunol (1975) 1.18

Personal accounts of the role of God in health and illness among older rural African American and White residents. J Cross Cult Gerontol (2000) 1.17

Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun (1976) 1.15

Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol (1979) 1.15

Elemental geochemistry of sedimentary rocks at Yellowknife Bay, Gale crater, Mars. Science (2013) 1.14

Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology (1989) 1.13

Simian foamy virus-induced immunosuppression in rabbits. J Gen Virol (1979) 1.12

Immune and virus-induced interferons may activate cells by different derepressional mechanisms. Nature (1980) 1.12

Spinal lipomas in children: outcome of 270 procedures. Pediatr Neurosurg (1997) 1.11

Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol (1980) 1.10

Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis. J Infect Dis (1998) 1.10

Detection of anti-interferon antibodies in systemic lupus erythematosus. Clin Exp Rheumatol (1985) 1.10

Synergistic effects of gamma interferon on inflammatory mediators that induce interleukin-6 gene expression and secretion by human retinal pigment epithelial cells. Clin Diagn Lab Immunol (1994) 1.10

Simultaneous generation of tuberculin-type and cutaneous basophilic hypersensitivity at separate sites in the guinea pig. Int Arch Allergy Appl Immunol (1979) 1.09

HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch Ophthalmol (1986) 1.09

Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol (1997) 1.08

Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08

Mindfulness meditation-related pain relief: evidence for unique brain mechanisms in the regulation of pain. Neurosci Lett (2012) 1.08

'Idiopathic' nephrotic syndrome is not always idiopathic. Tex Med (1990) 1.07

Interferon-induced enhancement of IgE-mediated histamine release from human basophils requires RNA synthesis. J Immunol (1979) 1.07

Complement-mediated release of histamine from human basophils. II. Biochemical characterization of the reaction. J Immunol (1976) 1.05

Class II antigen expression and gamma interferon modulation of monocytes and retinal pigment epithelial cells from patients with retinitis pigmentosa. Clin Immunol Immunopathol (1985) 1.03

Induction of an inhibitor of interferon action in a mouse lymphokine preparation. Infect Immun (1979) 1.03

Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol (2000) 1.03

In situ radiometric and exposure age dating of the martian surface. Science (2013) 1.03

Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect Immun (2000) 1.03

The Opportunity Rover's Athena science investigation at Meridiani Planum, Mars. Science (2004) 1.03

High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med (1996) 1.02

Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. J Immunol (1985) 1.01

Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease. Blood (1982) 1.01

Partial amino acid sequences of chicken and turkey immunoglobulin light chains. Homology with mammalian lambda chains. Biochemistry (1971) 0.99

A comparison of New World alphaviruses in the western equine encephalomyelitis complex by immunochemical and oligonucleotide fingerprint techniques. J Gen Virol (1980) 0.98

Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol (1989) 0.98

Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis (1994) 0.97

Release of slow reacting substance of anaphylaxis from human leukocytes. J Immunol (1974) 0.97

Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor. J Immunol (1976) 0.97

Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2001) 0.95

Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis. Curr Eye Res (1986) 0.95

RT-PCR assay for heme oxygenase-1 and heme oxygenase-2: a sensitive method to estimate cellular oxidative damage. Ann N Y Acad Sci (1994) 0.95

Evaluation of Ia expression in rat ocular tissues following inoculation with interferon-gamma. Exp Eye Res (1990) 0.95

Positive interaction between agonists in the aggregation response of human blood platelets: interation between ADP, adrenaline and vasopressin. Br J Haematol (1980) 0.95